Patents and Public Health Legalising the Policy Thoughts in the Doha TRIPS Declaration of 14 November 2001
Do patents rules prevent countries from acquiring affordable medicines? A number of legal experts and governments have felt that the WTO, in particular the TRIPS Agreement, forces countries to favour patents over public health. The WTO sought to settle this dispute by concluding the Public Health De...
Saved in:
Main Author: | Law, Andrew (auth) |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Nomos Verlagsgesellschaft mbH & Co. KG
2009
|
Series: | Munich Intellectual Property Law Center - MIPLC
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patents in the Food Sector A Retrospective with Special Emphasis on the TRIPs Agreement
by: Willnegger, Eva
Published: (2008) -
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
by: Donghi, Monica
Published: (2014) -
Patenting Proteomics Patentability and Scope of Protection of Three-Dimensional Protein Structure Claims under German, European and US law
by: Schuster, Martina
Published: (2010) -
Patentability Requirements for Nanotechnological Inventions An Approach from the European Patent Convention Perspective
by: Cisneros, Mario
Published: (2009) -
Second Generation Patents in Pharmaceutical Innovation
by: Ahn, Hyewon
Published: (2014)